Impact of cathepsin B on the interstitial fluid proteome of murine breast cancers

Biochimie

Volumn 122, Issue , 2016, Pages 88-98

  Gomez Auli, Alejandro ^a   Hillebrand, Larissa Elisabeth ^a   Biniossek, Martin Lothar ^a   Peters, Christoph ^a,b   Reinheckel, Thomas ^a,b   Schilling, Oliver ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cathepsins; Ectodomain shedding; Interstitial fluid; Proteases; Proteomics; Tumor microenvironment

Indexed keywords

ALPHA 1B GLYCOPROTEIN; CATHEPSIN B; GLYCOPROTEIN; MUP8 PROTEIN; PROTEINASE; PROTEINASE INHIBITOR; PROTEOME; UNCLASSIFIED DRUG; MAJOR URINARY PROTEINS; PEPTIDE HYDROLASE; PROTEIN; VIRUS T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; FEMALE; GENOTYPE; INTERSTITIAL FLUID; MOUSE; NONHUMAN; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN SECRETION; PROTEOMICS; QUANTITATIVE ANALYSIS; ANIMAL; EXPERIMENTAL MAMMARY NEOPLASM; EXTRACELLULAR FLUID; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LIQUID CHROMATOGRAPHY; METABOLISM; POLYOMAVIRUS; PROCEDURES; SECRETION (PROCESS); TANDEM MASS SPECTROMETRY; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BLOTTING, WESTERN; CATHEPSIN B; CHROMATOGRAPHY, LIQUID; EXTRACELLULAR FLUID; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE, KNOCKOUT; MICE, TRANSGENIC; PEPTIDE HYDROLASES; POLYOMAVIRUS; PROTEASE INHIBITORS; PROTEINS; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84957851489     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2015.10.009     Document Type: Article

References (57)

1. D. Hanahan, and L.M. Coussens Accessories to the crime: functions of cells recruited to the tumor microenvironment Cancer Cell 21 2012 309 322 10.1016/j.ccr.2012.02.022
2. K. Polyak, and R. Kalluri The role of the microenvironment in mammary gland development and cancer Cold Spring Harb. Perspect. Biol. 2 2010 a003244 10.1101/cshperspect.a003244
3. D.F. Quail, and J.A. Joyce Microenvironmental regulation of tumor progression and metastasis Nat. Med. 19 2013 1423 1437 10.1038/nm.3394
4. H. Wiig, O. Tenstad, P.O. Iversen, R. Kalluri, and R. Bjerkvig Interstitial fluid: the overlooked component of the tumor microenvironment? Fibrogenes. Tissue Repair 3 2010 12 10.1186/1755-1536-3-12
5. M. Makridakis, and A. Vlahou Secretome proteomics for discovery of cancer biomarkers J. Proteom. 73 2010 2291 22305
6. F. Mbeunkui, and D.J. Johann Jr. Cancer and the tumor microenvironment: a review of an essential relationship Cancer Chemother. Pharmacol. 63 2009 571 582 10.1007/s00280-008-0881-9
7. L. Rønnov-Jessen, O.W. Petersen, and M.J. Bissell Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction Physiol. Rev. 76 1996 69 125
8. G.S. Karagiannis, M.P. Pavlou, and E.P. Diamandis Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology Mol. Oncol. 4 2010 496 510 10.1016/j.molonc.2010.09.001
9. G. Baronzio, G. Parmar, M. Baronzio, and M. Kiselevsky Tumor interstitial fluid: proteomic determination as a possible source of biomarkers Cancer Genom. Proteom. 11 2014 225 237
10. H. Haslene-Hox, O. Tenstad, and H. Wiig Interstitial fluid-A reflection of the tumor cell microenvironment and secretome Biochim. Biophys. Acta 1834 2013 2336 2346 10.1016/j.bbapap.2013.01.028
11. V. Kulasingam, and E.P. Diamandis Tissue culture-based breast cancer biomarker discovery platform Int. J. Cancer 123 2008 2007 2012 10.1002/ijc.23844
12. J.E. Celis, J.M.A. Moreira, T. Cabezón, P. Gromov, E. Friis, F. Rank, and et al. Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interaction Mol. Cell. Proteom. 4 2005 492 522 10.1074/mcp.M500030-MCP200
13. C.-M. Huang, H.N. Ananthaswamy, S. Barnes, Y. Ma, M. Kawai, and C.A. Elmets Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses Proteomics 6 2006 6107 6116 10.1002/pmic.200600287
14. H. Haslene-Hox, E. Oveland, K. Woie, H.B. Salvesen, H. Wiig, and O. Tenstad Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue Biochim. Biophys. Acta 1834 2013 2347 2359 10.1016/j.bbapap.2013.05.011
15. E. Oveland, T. V Karlsen, H. Haslene-Hox, E. Semaeva, B. Janaczyk, O. Tenstad, and et al. Proteomic evaluation of inflammatory proteins in rat spleen interstitial fluid and lymph during LPS-induced systemic inflammation reveals increased levels of ADAMST1 J. Proteome Res. 11 2012 5338 5349 10.1021/pr3005666
16. J. Reiser, B. Adair, and T. Reinheckel Specialized roles for cysteine cathepsins in health and disease J. Clin. Investig. 120 2010 3421 3431 10.1172/JCI42918
17. S.D. Mason, and J.A. Joyce Proteolytic networks in cancer Trends Cell Biol. 21 2011 228 237 10.1016/j.tcb.2010.12.002
18. P. Lu, K. Takai, V.M. Weaver, and Z. Werb Extracellular matrix degradation and remodeling in development and disease Cold Spring Harb. Perspect. Biol. 3 2011 10.1101/cshperspect.a005058
19. L. Sevenich, and J.A. Joyce Pericellular proteolysis in cancer Genes Dev. 28 2014 2331 2347 10.1101/gad.250647.114
20. C. Jedeszko, and B.F. Sloane Cysteine cathepsins in human cancer Biol. Chem. 385 2004 1017 1027 10.1515/BC.2004.132
21. N.D. Rawlings, M. Waller, A.J. Barrett, and A. Bateman MEROPS: the database of proteolytic enzymes, their substrates and inhibitors Nucleic Acids Res. 42 2014 D503 D509 10.1093/nar/gkt953
22. D. Turk, and G. Guncar Lysosomal cysteine proteases (cathepsins): promising drug targets Acta Crystallogr. D. Biol. Crystallogr. 59 2003 203 213
23. O. Vasiljeva, T. Reinheckel, C. Peters, D. Turk, V. Turk, and B. Turk Emerging roles of cysteine cathepsins in disease and their potential as drug targets Curr. Pharm. Des. 13 2007 387 403
24. J.A. Foekens, J. Kos, H.A. Peters, M. Krasovec, M.P. Look, N. Cimerman, and et al. Prognostic significance of cathepsins B and L in primary human breast cancer J. Clin. Oncol. 16 1998 1013 1021
25. M.A. Nouh, M.M. Mohamed, M. El-Shinawi, M.A. Shaalan, D. Cavallo-Medved, H.M. Khaled, and et al. Cathepsin B: a potential prognostic marker for inflammatory breast cancer J. Transl. Med. 9 2011 1 10.1186/1479-5876-9-1
26. N. Harbeck, U. Alt, U. Berger, A. Krüger, C. Thomssen, F. Jänicke, and et al. Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy Clin. Cancer Res. 7 2001 2757 2764
27. Q. Chen, J. Fei, L. Wu, Z. Jiang, Y. Wu, Y. Zheng, and et al. Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients Oncol. Lett. 2 2011 693 699 10.3892/ol.2011.302
28. C.T. Guy, R.D. Cardiff, and W.J. Muller Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease Mol. Cell. Biol. 12 1992 954 961
29. O. Vasiljeva, A. Papazoglou, A. Krüger, H. Brodoefel, M. Korovin, J. Deussing, and et al. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer Cancer Res. 66 2006 5242 5250 10.1158/0008-5472.CAN-05-4463
30. L. Sevenich, F. Werner, M. Gajda, U. Schurigt, C. Sieber, S. Müller, and et al. Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice Oncogene 30 2011 54 64 10.1038/onc.2010.387
31. F. Bengsch, A. Buck, S.C. Günther, J.R. Seiz, M. Tacke, D. Pfeifer, and et al. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression Oncogene 33 2014 4474 4484 10.1038/onc.2013.395
32. S. Tholen, M.L. Biniossek, A.-L. Geßler, S. Müller, J. Weißer, J.N. Kizhakkedathu, and et al. Contribution of cathepsin L to secretome composition and cleavage pattern of mouse embryonic fibroblasts Biol. Chem. 392 2011 961 971 10.1515/BC-2011-162
33. S. Tholen, M.L. Biniossek, M. Gansz, A. Gomez-Auli, F. Bengsch, A. Noel, and et al. Deletion of cysteine cathepsins B or L yields differential impacts on murine skin proteome and degradome Mol. Cell. Proteom. 12 2013 611 625 10.1074/mcp.M112.017962
34. S. Tholen, M.L. Biniossek, M. Gansz, T.D. Ahrens, M. Schlimpert, J.N. Kizhakkedathu, and et al. Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis Cell. Mol. Life Sci. 71 2014 899 916 10.1007/s00018-013-1406-1
35. H. Wiig, K. Aukland, and O. Tenstad Isolation of interstitial fluid from rat mammary tumors by a centrifugation method Am. J. Physiol. Hear. Circ. Physiol. 284 2003 H416 H424 10.1152/ajpheart.00327.2002
36. H. Haslene-Hox, E. Oveland, K.C. Berg, O. Kolmannskog, K. Woie, H.B. Salvesen, and et al. A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue PLoS One 6 2011 e19217 10.1371/journal.pone.0019217
37. H. Shahinian, D. Loessner, M.L. Biniossek, J.N. Kizhakkedathu, J.A. Clements, V. Magdolen, and et al. Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells Mol. Oncol. 8 2014 68 82 10.1016/j.molonc.2013.09.003
38. P.J. Boersema, R. Raijmakers, S. Lemeer, S. Mohammed, and A.J.R. Heck Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics Nat. Protoc. 4 2009 484 494 10.1038/nprot.2009.21
39. J. Rappsilber, Y. Ishihama, and M. Mann Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics Anal. Chem. 75 2003 663 670
40. J. Cox, and M. Mann MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification Nat. Biotechnol. 26 2008 1367 1372 10.1038/nbt.1511
41. J. C. Oliveros, Venny. An interactive tool for comparing lists with Venn's diagrams, (n.d.). http://bioinfogp.cnb.csic.es/tools/venny/index.html (accessed July 1, 2015).
42. M.E. Ritchie, B. Phipson, D. Wu, Y. Hu, C.W. Law, W. Shi, and et al. limma powers differential expression analyses for RNA-sequencing and microarray studies Nucleic Acids Res. 43 2015 e47 10.1093/nar/gkv007
43. J.D. Bendtsen, L.J. Jensen, N. Blom, G. Von Heijne, and S. Brunak Feature-based prediction of non-classical and leaderless protein secretion Protein Eng. Des. Sel. 17 2004 349 356 10.1093/protein/gzh037
44. D.L. Tabb, L. Vega-Montoto, P.A. Rudnick, A.M. Variyath, A.-J.L. Ham, D.M. Bunk, and et al. Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry J. Proteome Res. 9 2010 761 776 10.1021/pr9006365
45. P. Bronsert, J. Weißer, M.L. Biniossek, M. Kuehs, B. Mayer, V. Drendel, and et al. Impact of routinely employed procedures for tissue processing on the proteomic analysis of formalin-fixed paraffin-embedded tissue Proteom. Clin. Appl. 8 2014 796 804 10.1002/prca.201300082
46. C. Planque, V. Kulasingam, C.R. Smith, K. Reckamp, L. Goodglick, and E.P. Diamandis Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines Mol. Cell. Proteom. 8 2009 2746 2758 10.1074/mcp.M900134-MCP200
47. H. Haslene-Hox, E. Oveland, K. Woie, H.B. Salvesen, O. Tenstad, and H. Wiig Distribution volumes of macromolecules in human ovarian and endometrial cancers-effects of extracellular matrix structure Am. J. Physiol. Hear. Circ. Physiol. 308 2015 H18 H28 10.1152/ajpheart.00672.2014
48. P. Videm, D. Gunasekaran, B. Schröder, B. Mayer, M.L. Biniossek, and O. Schilling Automated peptide mapping and protein-topographical annotation of proteomics data BMC Bioinform. 15 2014 207 10.1186/1471-2105-15-207
49. X.S. Puente, L.M. Sánchez, C.M. Overall, and C. López-Otín Human and mouse proteases: a comparative genomic approach Nat. Rev. Genet. 4 2003 544 558 10.1038/nrg1111
50. B. Schwanhäusser, D. Busse, N. Li, G. Dittmar, J. Schuchhardt, J. Wolf, and et al. Global quantification of mammalian gene expression control Nature 473 2011 337 342 10.1038/nature10098
51. P.H. Shaw, W.A. Held, and N.D. Hastie The gene family for major urinary proteins: expression in several secretory tissues of the mouse Cell 32 1983 755 761
52. R.J. Beynon, and J.L. Hurst Multiple roles of major urinary proteins in the house mouse, Mus domesticus Biochem. Soc. Trans. 31 2003 142 146 10.1042/
53. N. Fortelny, J.H. Cox, R. Kappelhoff, A.E. Starr, P.F. Lange, P. Pavlidis, and et al. Network analyses reveal pervasive functional regulation between proteases in the human protease web PLoS Biol. 12 2014 e1001869 10.1371/journal.pbio.1001869
54. N. Ishioka, N. Takahashi, and F.W. Putnam Amino acid sequence of human plasma alpha 1B-glycoprotein: homology to the immunoglobulin supergene family Proc. Natl. Acad. Sci. U. S. A. 83 1986 2363 2367
55. K. Jessie, J.J. Jayapalan, K.-C. Ong, Z.H. Abdul Rahim, R.M. Zain, K.-T. Wong, and et al. Aberrant proteins in the saliva of patients with oral squamous cell carcinoma Electrophoresis 34 2013 2495 2502 10.1002/elps.201300107
56. Y. Liu, X. Luo, H. Hu, R. Wang, Y. Sun, R. Zeng, and et al. Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer PLoS One 7 2012 e51748 10.1371/journal.pone.0051748
57. M. Tian, Y.-Z. Cui, G.-H. Song, M.-J. Zong, X.-Y. Zhou, Y. Chen, and et al. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients BMC Cancer 8 2008 241 10.1186/1471-2407-8-241